01664nas a2200493   4500000000100000008004100001260001300042653001000055653002800065653001100093653004400104653001100148653001200159653000900171653003900180653001800219653003200237653002200269100001400291700002200305700001500327700001600342700001700358700001700375700001500392700001900407700001700426700001500443700001800458700001500476700001400491700001400505700001400519700002000533700001600553700001300569700001900582245007100601300001100672490000700683050001700690520044900707022001401156       2007                            d  c2007 Nov10aAdult10aDiagnosis, Differential10aFemale10aHematopoietic Stem Cell Transplantation10aHumans10aleprosy10aMale10aPeripheral Nervous System Diseases10aSkin Diseases10aTransplantation, Homologous10aTreatment Outcome1 aPieroni F1 aStracieri A B P L1 aMoraes D A1 aPaton E J A1 aSaggioro F P1 aBarros G M N1 aBarros J C1 aOliveira M C B1 aCoutinho M A1 aCastro N S1 aVigoritto A C1 aTrabasso P1 aSouza C A1 aSouza M P1 aMauad M A1 aColturato V A R1 aSimões B P1 aFoss N P1 aVoltarelli J C00aSix cases of leprosy associated with allogeneic hematopoietic SCT.  a859-630 v40  aPIERONI 20073 a<p>We report here the first six cases of leprosy associated with HLA-identical allogeneic SCT in different phases and with different findings and outcomes. Skin and peripheral nerves may be sites of leprosy associated with SCT, stressing the importance of differential diagnosis between leprosy and GVHD or drug reactions. Clinical manifestations of leprosy before or after transplantation did not influence the outcome of SCT in our cases.</p>  a0268-3369